Your Ultimate Solution to Clinical Data

NeosysX offers cutting-edge technology and world-class expertise to enhance data visualization and statistical analysis, AI-powered medical writing providing bespoke and flexible solutions to accelerate your clinical programs.

Our Features

01.

Advanced Tech

Generative AI Technology

Advanced R based Analysis Tools

02.

Cost Effective and Speed

AI technology automates analysis reducing costs below the industry average.

03.

Real-time Analysis and Reports Generation

ShinyVista and NarraSnap provides real-time data analysis and reports generation

04.

Quality and Professionals

Ph.D. biostatisticians with rich industry experience. Data scientists experts in AL language models.

05.

Client Focus

Flexibility and adaptive to Client request.

Signature Products

Fast track your clinical trial decision-making and approval with our extensive expertise of tailored solutions.

Create onelogo for a data visualization tool called ShinyVista_edited.png

ShinyVista®
Data Visualization and Interactive Analysis Tool

NarraSnap®
AI LLM Patient Narrative Tool

Statistical Programming

CDISC-Compliant Programming
Multi-Language Expertise
Interactive R Shiny App Solutions

Statistical Consulting

Clinical Trial Design
Trial Optimization
Development Strategy

Pharmacovigilance Support

Data Monitoring Committee (DMC)
Development Safety Update Report (DSUR) Automation using AL NLM

Medical Writing

Clinical Study Report
Investigator’s Brochure

Our Vision

At NeosysX Inc., we are driven by our core values: Automation and Efficacy, Expert execution, High Quality, and Cost-Effectiveness.

We strive to revolutionize the biopharma sector by delivering automated, high-quality solutions that ensure efficacy and exceed expectations. Leveraging our expertise in data science and biostatistics, we execute with precision to provide cost-effective outcomes that set industry benchmarks.

Join us as we lead the way in transforming biostatistics and medical writing through innovation, efficiency, and unparalleled service.

Announcements & News

NeosysX has closely follows Regulatory guidance on R use and AI related technology.

European Medicines Agency (EMA) Guidance

In 2020, the European Medicines Agency published a Notice to sponsors on validation and qualification of computerised systems used in clinical trials and the associated Q&A.
“The sponsor may rely on qualification documentation provided by the vendor, if the qualification activities performed by the vendor have been assessed as adequate."

FDA do not require the use of any specific software for statistical analyses.

In 2015, the FDA released a Statistical Software Clarifying Statement. This document states that they do not require the use of any specific software for statistical analyses. However, the FDA requests that software package(s) be documented upon submission. This documentation must include version and build identification.

Contact

NeosysX Inc.

Work with the best and brightest minds dedicated to pushing the boundaries of data & technology, to accelerate decision making and improve clinical development.

Submit RFI

Book a Demo